A systematic review on anti-Alzheimer's disease activity of prescription Kangen-karyu-Reference-Cited by-同舟云学术

A systematic review on anti-Alzheimer's disease activity of prescription Kangen-karyu

Published:2020-04-30 Issue:2 Volume:14 Page:61-66
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Paudel Pradeep¹²,Park Chan Hum³,Jung Hyun Ah⁴,Yokozawa Takako⁵,Choi Jae Sue¹

Affiliation:

1. Department of Food and Life Science, Pukyong National University, Busan, Republic of Korea.

2. National Center for Natural Product Research, The University of Mississippi, Oxford, USA.

3. Department of Medicinal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong, Republic of Korea.

4. Department of Food Science and Human Nutrition, Jeonbuk National University, Jeonju, Republic of Korea.

5. Graduate School Science and Engineering for Research, University of Toyama, Toyama, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.03013/_pdf

Reference41 articles.

1. 1. Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol. 2008; 7:812-826.

2. 2. Lundkvist J, Halldin MM, Sandin J, Nordvall G, Forsell P, Svensson S, Jansson L, Johansson G, Winblad B, Ekstrand J. The battle of Alzheimer's disease - the beginning of the future unleashing the potential of academic discoveries. Front Pharmacol. 2014; 5:102.

3. 3. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol. 1994; 10:373-403.

4. 4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science. 2002; 297:353-356.

5. 5. Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med. 2012; 2:a006148.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction;Journal of Ethnopharmacology;2024-01

2. Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turns;Drug Discoveries & Therapeutics;2023-12-31

3. Parameterization and validation of a new AMBER force field for an oxovanadium (IV) complex with therapeutic potential implications in Alzheimer's disease;Journal of Molecular Graphics and Modelling;2023-07

4. Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials;Frontiers in Pharmacology;2023-06-01

5. Molecular Dynamics-Assisted Interaction of Vanadium Complex–AMPK: From Force Field Development to Biological Application for Alzheimer’s Treatment;The Journal of Physical Chemistry B;2023-01-05